Brief: Castle Biosciences posts Q1 basic EPS USD -1.1
03/05/2023 23:28
May 3 (Reuters) - Castle Biosciences Q1 revenue USD 42.037 million. * Q1 pretax profit USD -29.19 million * Q1 operating expenses USD 73.559 million * Q1 net income USD -29.204 million * Q1 operating income USD -31.522 million * Q1 basic EPS USD -1.1 * Q1 gross margin 70.5% * Q1 adjusted gross margin 76.5%
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million